Hints and tips:
...You get immediate confrontation of views and discussion,” said Bernard Poussot, the former chief executive officer and president of Wyeth, who was appointed a non-executive director in 2010....
...In a statement, the company also confirmed the anticipated departure of Bernard Poussot, the chief executive of Wyeth who co-ordinated the takeover....
...“The name of the new company is Pfizer,” was the blunt announcement of Jeff Kindler, Pfizer’s chief executive, as he sat alongside Bernard Poussot, the outgoing head of Wyeth....
...In fact, on July 6 last year, Kindler had already made a first formal approach to Bernard Poussot, his opposite at Wyeth, formerly American Home Products....
...Several chief executives, including Andrew Witty at GlaxoSmithKline and Bernard Poussot at Wyeth, have already said they are suspending share buybacks to take advantage of the dislocation in the markets...
...“We tested and tortured Bernard with a variety of assignments over the last five years.” Mr Poussot, born in France but now a US citizen, did not know he was a candidate until a year ago....
...Similarly, Bernard Poussot, the long-standing chief operations officer at Wyeth, took observers by surprise with the speed of the announcement in September that he would replace Bob Essner, who remains chairman...
...Bernard Poussot, head of Wyeth’s pharmaceuticals business, said: “I think that says we have a lot of potential. The lionshare will be internationally, but we still expect some growth in the US.”...
...Bernard Poussot, head of Wyeth’s pharmaceutical operations, said: “Obviously it is a first step. We’re also looking internationally....
International Edition